EUVIMEDOntdek EUVIMED
Open access · CC BY-NC 4.0

Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study

Julia Lichtenstein, Irene Sterpu iD, Pelle G Lindqvist iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14987 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2024. Written by Julia Lichtenstein and 2 co-authors. Institution: Clinical Sciences and Education, Karolinska Institutet, Stockholm, Sweden. Major MEDLINE topics: Postpartum Hemorrhage, Fatty Acids, Omega-3, Registries. Cited 2 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Vetenskapsrådet.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Introduction

Although Omega‐3 is thought to have anticoagulative properties, the potential untoward effects of Omega‐3 during pregnancy have not been investigated. No previous studies have been made to specifically assess its effect on postpartum hemorrhage (PPH). Our aim was to determine if an association exists between Omega‐3 intake during pregnancy and profuse PPH or massive PPH. Material and Methods Data on all deliveries that occurred at Karolinska University Hospital during the years 2007–2011 ( n = 41 139) was collected from the medical record of Obstetrix, maternal health and delivery chart system. Women with reported Omega‐3 use in early pregnancy were considered exposed and all other as unexposed. Bivariate and adjusted multivariate analysis was performed on main outcomes.

Results

Omega‐3 use was associated with 25% increased odds of PPH (adjusted odds ratio (aOR) 1.25, 95% confidence interval [CI] (1.06–1.47)) and a more than doubled odds of massive PPH (aOR 2.36, 95% CI 1.26–4.44). In addition, there was a minor increase in the amount of blood loss. Although few, women on low‐dose discontinued terminated at 36th week showed no significant association to blood loss measurements.

Conclusions

Our observational findings showed 25% higher odds of PPH and two times higher odds of massive PPH in women who reported using Omega‐3 in early pregnancy. Our findings give some support to advocate discontinued use of Omega‐3 in late pregnancy.

Subjects

MeSH terms (MEDLINE)

Postpartum HemorrhageFatty Acids, Omega-3RegistriesHumansFemalePregnancyAdultDietary SupplementsSweden

Author keywords

fatty acidomega‐3postpartum hemorrhagepregnancypreterm birthsupplements

Substances

Fatty Acids, Omega-3

Authors and institutions

  • Clinical Sciences and Education, Karolinska Institutet, Stockholm, Sweden.
  • Division of Obstetrics and Gynecology, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Hospital Huddinge, Stockholm, Sweden.

ORCID profiles: Irene Sterpu, Pelle G Lindqvist

Funding

  • Vetenskapsrådet

Cite

APA

Lichtenstein, J., Sterpu, I., & Lindqvist, P. G. (2024). Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14987

Vancouver

Lichtenstein J, Sterpu I, Lindqvist PG. Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14987

BibTeX
@article{Lichtenstein2024,
  author = {Lichtenstein, Julia and Sterpu, Irene and Lindqvist, Pelle G},
  title = {Does Omega‐3 supplementation increase profuse postpartum hemorrhage? A hospital‐based register study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14987}
}
Start for free →